Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.24.34 extracted from

  • Khademi, M.; Bornsen, L.; Rafatnia, F.; Andersson, M.; Brundin, L.; Piehl, F.; Sellebjerg, F.; Olsson, T.
    The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers (2009), Eur. J. Neurol., 16, 528-536.
    View publication on PubMed
Search for more literature for 3.4.24.34

Organism

Organism UniProt Comment Textmining